The European patent system: dealing with emerging technologies

References

• Andreasen , M. 2009 . Two stories about biotech patenting from the “silent majority” in Europe . Public understanding of science , 19 ( 3 ) : 355 – 371 .
   Web of Science ®Google Scholar
• Aymé , S. , Matthijs , G. and Soini , S. 2008 . Patenting and licensing in genetic testing . European journal of human genetics , 16 : 405 – 411 .
   PubMed Web of Science ®Google Scholar
• Baumgartner , C. 2006 . Exclusion by inclusion? On difficulties with regards to an effective ethical assessment of patenting in the field of agricultural bio-technology . Journal of agricultural and environmental ethics , 19 : 521 – 539 .
   Web of Science ®Google Scholar
• Benowitz , S. 2002 . French challenge to BRCA1 patent underlies European discontent . Journal of the National Cancer Institute , 94 ( 2 ) : 80 – 81 .
   PubMedGoogle Scholar
• Borrás , S. , Koutalakis , C. and Wendler , F. 2007 . European agencies and input legitimacy: EFSA, EMeA and EPO in the post-delegation phase . Journal of European integration , 29 ( 5 ) : 583 – 600 .
   Google Scholar
• Brownsword , R. 2008 . Rights, regulation and the technological revolution , New York : Oxford University Press .
   Google Scholar
• Burke , P. and Reitzig , M. 2007 . Measuring patent assessment quality: analyzing the degree and kind of (in) consistency in patent offices’ decision making . Research policy , 36 ( 9 ) : 1404 – 1430 .
   Web of Science ®Google Scholar
• Cohen , S. , Gareth , M. , and Royle , M. , 2008 . Litigating biotech patents in Europe . Intellectual asset management magazine . Available from http://www.integrityip.com/patent_Library/BiotechhitigationinEurope.pdf [Accessed March 2011].
   Google Scholar
• Cowan , R. , et al. 2006 . Policy options for the improvement of the European patent system (STOA Report /FWC/2005-28) . Brussels : Directorate General for Internal Policies
   Google Scholar
• Edfjäll , C. 2007 . European patent information 2007: EPO policy reformulated . World patent information , 30 ( 3 ) : 206 – 211 .
   Google Scholar
• Elsmore , J.M. 2009 . Quality and quantity: can we have both within the European patent system? . ERA-forum , 10 : 215 – 230 .
   Google Scholar
• European Commission , 2008 . Industrial property rights strategy . COM (2008) 465 . DG MARKT : Brussels .
   Google Scholar
• European Union . 1998 . Directive 98/44/EC of 6 July 1998 on legal protection of biotechnological inventions . Official journal L213 , 30 ( 7 ) : 13 – 21 .
   Google Scholar
• Ganguli , P. 2001 . Intellectual property rights: mothering innovations to markets . World patent information , 22 ( 1 ) : 43 – 52 .
   Google Scholar
• Guellec , D. and van Pottelsberghe de la Potterie , B. 2007 . The economics of the European patent system , New York : Oxford University Press .
   Google Scholar
• Hagel , F. 2008 . Including the right ingredients . Patent world. , 199 : 30 – 33 .
   Google Scholar
• Hagendijk , R. and Irwin , A. 2006 . Public deliberation and governance: engaging with science and technology in contemporary Europe . Minerva , 44 ( 2 ) : 167 – 184 .
   Web of Science ®Google Scholar
• Hall , B.H. 2004 . “ Prospects for improving US patent quality via postgrant opposition ” . In Innovation policy and the economy , Edited by: Jaffe , A. , Lerner , J. and Stern , S. 115 – 143 . London : MIT Press .
   Google Scholar
• Harhoff , D. 2009 . Economic cost–benefit analysis of a unified and integrated European patent litigation system , Germany : EU. Tender no. MARKT/,2008/06/D .
   Google Scholar
• Holzer , W. , 2005 . Patent litigation in Europe – an adventure . Seminar on IPR protection in Europe: reaching the European market , 19 – 20 July 2005, Bangkok .
   Google Scholar
• Jasanoff , S. 2005 . In the democracies of DNA: ontological uncertainty and political order in three states . New genetics and society , 24 ( 2 ) : 139 – 156 .
   PubMed Web of Science ®Google Scholar
• Johnston , J., and Wasunna , A. A. 2007 . Patents, biomedical research, and treatments: examining concerns, canvassing solutions . Hastings Centre report , 37 ( 1 ) : S1 – S36 .
   PubMed Web of Science ®Google Scholar
• Jones , W. 2002 . History of gene patent: tracing the development and application of commercial BRCA testing . Health and law journal , 10 : 124 – 146 .
   Google Scholar
• Majumder , M. 2008 . “ Ethical challenges of patenting “nature”: legal and economic accounts of altered nature as property ” . In Altering nature: concepts of nature and the natural in biotechnology debate , Edited by: Lusting , A. , Baruch , B. and Gerald , M.P. 199 – 275 . Berlin : Springer .
   Google Scholar
• Matthijs , G. , 2006 . The European opposition against the BRCA gene patents . Familial cancer , 95 – 102 .
   PubMed Web of Science ®Google Scholar
• Merrill , A. , Levin , R. and Myers , M. 2004 . A patent system for the 21st century , Washington, DC : The National Academies Press .
   Google Scholar
• Nuffield Council on Bioethics , 2002 . The ethics of patenting DNA . Available from: http://www.nuffieldbioethics.org/patenting-dna
   Google Scholar
• Picciotto , S. , 2001 . Democratizing the new global public sphere . Available from: http://www.lancs.ac.uk/staff/lwasp/demglobpub.pdf [Accessed May 2010].
   Google Scholar
• Roox , K. 2008 . Patent-related barriers to market entry for generic medicines in the European Union , Brussels : European Generic Medicines Association .
   Google Scholar
• Salter , B. , 2009 . Patents and morality: governing human embryonic stem cell science in Europe . Global Biopolitics Research Group, Centre for Biomedicine and Society. Available from: http://www.kcl.ac.uk/content/1/c6/03/03/66/PatentingandmoralityintheEU2.doc [Accessed April 2010].
   Google Scholar
• Salter , B. and Salter , C. 2007 . Bioethics and the global moral economy: the cultural politics of human embryonic stem cell science . Science, technology and human values , 32 ( 5 ) : 554 – 581 .
   Web of Science ®Google Scholar
• Schneider , I. 2009a . Governing the patent system in Europe: the EPO's supranational autonomy and its need for a regulatory perspective . Science and public policy , 36 ( 8 ) : 619 – 629 .
   Web of Science ®Google Scholar
• Schneider , I. 2009b . “ Can patent legislation make a difference? Bringing parliaments and civil society into patent governance ” . In Politics of intellectual property , Edited by: Haunss , S. and Shadlen , K.C. 129 – 157 . Cheltenham : Edwar Elgar .
   Google Scholar
• Schrell , A. , Bauser , H. and Brunner , H. 2007 . Biotechnology patenting policy in the European Union – as exemplified by the development in Germany . Advances in biochemical engineering and biotechnology , 107 : 13 – 40 .
   PubMed Web of Science ®Google Scholar
• Shang , R. 2009 . Inter partes re-examination and improving patent quality . Northwestern journal of technology and intellectual property , 7 ( 2 ) : 185 – 120 .
   Google Scholar
• Soini , S. , Aymé , S. and Matthijs , G. 2008 . Patenting and licensing in genetic testing: ethical, legal and social issues . European journal of human genetics , 16 : S10 – S50 .
   Web of Science ®Google Scholar
• Sterckx , S. 2008 . The European Patent Convention and the (non) patentability of human embryonic stem cells – the WARF case . Intellectual property quarterly , 4 : 478 – 495 .
   Google Scholar
• Tanner , A. , 2000 . Europe patent covering human cloning was “mistake” . Reuters Newswire . Available from:http://www.grain.org/bio-ipr/?id;=;96 [Accessed April 2010].
   Google Scholar
• Thaker , S. , 2003 . The criticality of non-market strategies: the European Biotechnology Patents Directive . Available from: www.kellogg.northwestern.edu [Accessed September 2010].
   Google Scholar
• Ullrich , H. 2006 . National, European and Community patent protection: time for reconsideration . EUI working papers law , 4 : 1 – 41 .
   Google Scholar
• Van Pottelsberghe de la Potterie , B. 2009 . Lost property: the European patent system and why it doesn't work . Bruegel Blueprint Series , 11 : 3 – 71 .
   Google Scholar
• Wagner , R.P. 2009 . Understanding patent quality mechanisms . University of Pennsylvania law review , 157 ( 2135 ) : 1 – 38 .
   Google Scholar
• White , E.K. 2004 . An efficient way to improve patent quality for plant varieties . Northwestern journal of technology and intellectual property , 3 : 79 – 91 .
   Google Scholar
• Zimmer , J. F. and Sethmann , S. 2005 . The immoral gene: does it really exist? . Science and engineering ethics , 11 ( 1 ) : 97 – 104 .
   PubMed Web of Science ®Google Scholar